Development of an anticonvulsant agent based on its effect on  -aminobutyric acid metabolism.
D000613:Aminobutyrates / Q000378:metabolism*; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D002645:Chickens; D006834:Hydrazines / Q000494:pharmacology; D006931:Hyperbaric Oxygenation; D007539:Isonicotinic Acids / Q000494:pharmacology*; D008297:Male; D011736:Pyridoxine / Q000494:pharmacology*
D000613:Aminobutyrates; D000927:Anticonvulsants; D006834:Hydrazines; D007539:Isonicotinic Acids; D011736:Pyridoxine